Edition:
United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

10.97USD
22 May 2019
Change (% chg)

$0.04 (+0.37%)
Prev Close
$10.93
Open
$10.88
Day's High
$11.15
Day's Low
$10.65
Volume
600,158
Avg. Vol
855,974
52-wk High
$36.35
52-wk Low
$9.58

Wasman, Jane 

Ms. Jane Wasman, J.D., is President - International, General Counsel, Corporate Secretary of Acorda Therapeutics, Inc. Prior to that, from January 2012 until October 2012, she was our Chief, Strategic Development, General Counsel and Corporate Secretary; and from May 2004 until January 2012, she was our Executive Vice President, General Counsel and Corporate Secretary. Prior to joining the Company, from 1995 to 2004, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and Associate General Counsel responsible for legal support for U.S. Pharmaceuticals operations, including sales, marketing and compliance; FDA regulatory matters; licensing and mergers and acquisitions; and global research and development. She served as Staff Vice President, International in 2001 and as Staff Vice President, European Operations-Legal from 1998 to 2000. Previously, Ms. Wasman specialized in litigation at Fried, Frank, Harris, Shriver & Jacobson. She also served as Associate Counsel to the U.S. Senate Committee on Veterans’ Affairs. Ms. Wasman graduated Magna Cum Laude and Phi Beta Kappa from Princeton University and earned her J.D. from Harvard Law School. Ms. Wasman is a member and Chair of the board of directors of Sellas Life Sciences Group, Inc., where she also serves as Chair of the Nominations and Governance Committee and as a member of the Compensation Committee. Ms. Wasman is also a member of the board of directors and the executive committee of the board of the NewYork BIO.

Basic Compensation

Total Annual Compensation, USD 892,177
Restricted Stock Awards, USD 459,296
Long-Term Incentive Plans, USD --
All Other, USD 635,071
Fiscal Year Total, USD 1,986,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 9,147 52,126.00
Name Fiscal Year Total

Ron Cohen

2,016,980

Richard Batycky

--

David Lawrence

999,491

Jane Wasman

1,986,540

Burkhard Blank

1,477,570

Andrew Hindman

1,605,310
As Of  30 Dec 2017